Market Cap 2.34B
Revenue (ttm) 62.90M
Net Income (ttm) -204.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -325.33%
Debt to Equity Ratio 0.02
Volume 2,578,998
Avg Vol 7,261,618
Day's Range N/A - N/A
Shares Out 351.12M
Stochastic %K 19%
Beta 1.52
Analysts Strong Sell
Price Target $13.30

Company Profile

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment of high-risk or high-grade IDH1-mutant astrocytoma with safusidenib against place...

Industry: Biotechnology
Sector: Healthcare
Phone: 332 208 6102
Address:
1500 Broadway, Suite 1401, New York, United States
Incognito_21
Incognito_21 Sep. 2 at 4:20 PM
$NUVB printable by 2028 don’t miss the boat
0 · Reply
Incognito_21
Incognito_21 Sep. 2 at 4:19 PM
$NUVB couple of conferences leading up to the November earnings should get things going
0 · Reply
Belisimo
Belisimo Sep. 1 at 6:21 PM
$NUVB Jeff usvckmoose
1 · Reply
Rawbinhood
Rawbinhood Sep. 1 at 6:19 PM
$NUVB 1. IBTROZI® (taletrectinib) — ROS1-Positive Non-Small Cell Lung Cancer (NSCLC)The company will present new subgroup analyses of pivotal data from its Phase 2 TRUST-I and TRUST-II trials. These findings will detail efficacy and safety across specific patient subgroups at:IASLC 2026 World Conference on Lung Cancer (WCLC): September 12–15, 2026, in Seoul, South Korea.European Society for Medical Oncology (ESMO) Annual Congress: October 23–27, 2026, in Madrid, Spain.Note: The FDA accepted a supplemental New Drug Application (sNDA) with updated data for IBTROZI, carrying a target action date of January 4, 2027.
0 · Reply
vu_jade
vu_jade Sep. 1 at 3:09 PM
$NUVB another great entry area
0 · Reply
Physical_Graffiti
Physical_Graffiti Sep. 1 at 3:05 PM
$NUVB beautiful chart
1 · Reply
n9zro
n9zro Sep. 1 at 2:03 PM
$NUVB Why has this stalled ?
1 · Reply
AliThePoorMan
AliThePoorMan Sep. 1 at 11:58 AM
1 · Reply
AliThePoorMan
AliThePoorMan Sep. 1 at 11:55 AM
0 · Reply
JuggernautRaider
JuggernautRaider Sep. 1 at 11:23 AM
$PHVS $TNXP $NUVB $MIST Yep 🤷‍♂️ 👍 🇺🇸 This Dude is Nuts. How many Cowboys from Ohio does America got left? 🌰 🥜 🤤 https://www.linkedin.com/posts/jeff-conroy-80a39323_i-wish-tnxp-which-i-still-own-a-paltry-01-activity-7500507145864634369-E1Pa
0 · Reply
Latest News on NUVB
Nuvation Bio initiated with an Overweight at JPMorgan

2026-08-18T08:55:07.000Z - 15 days ago

Nuvation Bio initiated with an Overweight at JPMorgan


Nuvation Bio price target raised to $14 from $12 at B. Riley

2026-08-07T12:56:00.000Z - 26 days ago

Nuvation Bio price target raised to $14 from $12 at B. Riley


Nuvation Bio Slides: Corporate presentation

Aug 6, 2026, 9:00 AM EDT - 27 days ago

Nuvation Bio Slides: Corporate presentation


Nuvation Bio Earnings Call Transcript: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 27 days ago

Nuvation Bio Earnings Call Transcript: Q2 2026


Nuvation Bio Quarterly report: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 27 days ago

Nuvation Bio Quarterly report: Q2 2026


Nuvation Bio Earnings release: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 27 days ago

Nuvation Bio Earnings release: Q2 2026


Nuvation Bio reports Q2 EPS (18c), consensus (12c)

2026-08-06T11:45:31.000Z - 27 days ago

Nuvation Bio reports Q2 EPS (18c), consensus (12c)


Nuvation Bio Slides: Corporate presentation

Jul 20, 2026, 9:00 AM EDT - 6 weeks ago

Nuvation Bio Slides: Corporate presentation


Nuvation Bio announces data from the Phase 2 J201 study

2026-07-20T12:05:16.000Z - 6 weeks ago

Nuvation Bio announces data from the Phase 2 J201 study


Nuvation Bio falls -10.1%

2026-06-25T14:05:38.000Z - 2 months ago

Nuvation Bio falls -10.1%


Nuvation Bio Slides: Corporate presentation

Jun 15, 2026, 7:00 AM EDT - 2 months ago

Nuvation Bio Slides: Corporate presentation


Nuvation Bio Transcript: AGM 2026

May 21, 2026, 11:00 AM EDT - 3 months ago

Nuvation Bio Transcript: AGM 2026


Nuvation Bio: FDA accepts sNDA with updated data for IBTROZI

2026-05-07T06:20:14.000Z - 3 months ago

Nuvation Bio: FDA accepts sNDA with updated data for IBTROZI


Nuvation Bio to Participate in Upcoming Investor Conferences

May 5, 2026, 4:05 PM EDT - 3 months ago

Nuvation Bio to Participate in Upcoming Investor Conferences


Nuvation Bio Earnings Call Transcript: Q1 2026

May 4, 2026, 4:30 PM EDT - 4 months ago

Nuvation Bio Earnings Call Transcript: Q1 2026


Nuvation Bio Quarterly report: Q1 2026

May 4, 2026, 4:30 PM EDT - 4 months ago

Nuvation Bio Quarterly report: Q1 2026


Nuvation Bio Earnings release: Q1 2026

May 4, 2026, 4:30 PM EDT - 4 months ago

Nuvation Bio Earnings release: Q1 2026


Nuvation Bio reports Q1 EPS 1c, consensus 5c

2026-05-04T20:17:35.000Z - 4 months ago

Nuvation Bio reports Q1 EPS 1c, consensus 5c


Nuvation Bio Slides: Investor presentation

May 4, 2026, 4:00 PM EDT - 4 months ago

Nuvation Bio Slides: Investor presentation


Nuvation Bio Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 4 months ago

Nuvation Bio Proxy statement: Proxy filing


Nuvation Bio Slides: Corporate presentation

Apr 21, 2026, 7:00 AM EDT - 4 months ago

Nuvation Bio Slides: Corporate presentation


Nuvation Bio Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 4 months ago

Nuvation Bio Proxy statement: Proxy filing


Nuvation Bio Earnings Call Transcript: Q4 2025

Mar 2, 2026, 4:30 PM EST - 6 months ago

Nuvation Bio Earnings Call Transcript: Q4 2025


Nuvation Bio Annual report: Q4 2025

Mar 2, 2026, 4:30 PM EST - 6 months ago

Nuvation Bio Annual report: Q4 2025


Nuvation Bio Earnings release: Q4 2025

Mar 2, 2026, 4:30 PM EST - 6 months ago

Nuvation Bio Earnings release: Q4 2025


Nuvation Bio Slides: Corporate presentation

Mar 2, 2026, 7:00 AM EST - 6 months ago

Nuvation Bio Slides: Corporate presentation


Nuvation Bio Slides: Corporate presentation

Jan 12, 2026, 7:00 AM EST - 7 months ago

Nuvation Bio Slides: Corporate presentation


Nuvation Bio Slides: Corporate Presentation

Dec 1, 2025, 7:00 AM EST - 9 months ago

Nuvation Bio Slides: Corporate Presentation


Nuvation Bio Earnings Call Transcript: Q3 2025

Nov 3, 2025, 4:30 PM EST - 10 months ago

Nuvation Bio Earnings Call Transcript: Q3 2025


Nuvation Bio Quarterly report: Q3 2025

Nov 3, 2025, 4:30 PM EST - 10 months ago

Nuvation Bio Quarterly report: Q3 2025


Nuvation Bio Earnings release: Q3 2025

Nov 3, 2025, 4:30 PM EST - 10 months ago

Nuvation Bio Earnings release: Q3 2025


Nuvation Bio Slides: Corporate Presentation

Nov 2, 2025, 12:00 AM EDT - 10 months ago

Nuvation Bio Slides: Corporate Presentation


Nuvation Bio Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Nuvation Bio Earnings Call Transcript: Q2 2025


Nuvation Bio Quarterly report: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Nuvation Bio Quarterly report: Q2 2025


Nuvation Bio Earnings release: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Nuvation Bio Earnings release: Q2 2025


Nuvation Bio Slides: Corporate Presentation

Aug 6, 2025, 6:00 PM EDT - 1 year ago

Nuvation Bio Slides: Corporate Presentation


Nuvation Bio Transcript: FDA Announcement

Jun 12, 2025, 7:30 AM EDT - 1 year ago

Nuvation Bio Transcript: FDA Announcement


Nuvation Bio Press release: FDA Announcement

Jun 12, 2025, 7:30 AM EDT - 1 year ago

Nuvation Bio Press release: FDA Announcement


Nuvation Bio Slides: FDA Announcement

Jun 12, 2025, 7:30 AM EDT - 1 year ago

Nuvation Bio Slides: FDA Announcement


US FDA approves Nuvation Bio's lung cancer therapy

Jun 11, 2025, 1:45 PM EDT - 1 year ago

US FDA approves Nuvation Bio's lung cancer therapy


Nuvation Bio Earnings Call Transcript: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Nuvation Bio Earnings Call Transcript: Q1 2025


Nuvation Bio Quarterly report: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Nuvation Bio Quarterly report: Q1 2025


Nuvation Bio Earnings release: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Nuvation Bio Earnings release: Q1 2025


Incognito_21
Incognito_21 Sep. 2 at 4:20 PM
$NUVB printable by 2028 don’t miss the boat
0 · Reply
Incognito_21
Incognito_21 Sep. 2 at 4:19 PM
$NUVB couple of conferences leading up to the November earnings should get things going
0 · Reply
Belisimo
Belisimo Sep. 1 at 6:21 PM
$NUVB Jeff usvckmoose
1 · Reply
Rawbinhood
Rawbinhood Sep. 1 at 6:19 PM
$NUVB 1. IBTROZI® (taletrectinib) — ROS1-Positive Non-Small Cell Lung Cancer (NSCLC)The company will present new subgroup analyses of pivotal data from its Phase 2 TRUST-I and TRUST-II trials. These findings will detail efficacy and safety across specific patient subgroups at:IASLC 2026 World Conference on Lung Cancer (WCLC): September 12–15, 2026, in Seoul, South Korea.European Society for Medical Oncology (ESMO) Annual Congress: October 23–27, 2026, in Madrid, Spain.Note: The FDA accepted a supplemental New Drug Application (sNDA) with updated data for IBTROZI, carrying a target action date of January 4, 2027.
0 · Reply
vu_jade
vu_jade Sep. 1 at 3:09 PM
$NUVB another great entry area
0 · Reply
Physical_Graffiti
Physical_Graffiti Sep. 1 at 3:05 PM
$NUVB beautiful chart
1 · Reply
n9zro
n9zro Sep. 1 at 2:03 PM
$NUVB Why has this stalled ?
1 · Reply
AliThePoorMan
AliThePoorMan Sep. 1 at 11:58 AM
1 · Reply
AliThePoorMan
AliThePoorMan Sep. 1 at 11:55 AM
0 · Reply
JuggernautRaider
JuggernautRaider Sep. 1 at 11:23 AM
$PHVS $TNXP $NUVB $MIST Yep 🤷‍♂️ 👍 🇺🇸 This Dude is Nuts. How many Cowboys from Ohio does America got left? 🌰 🥜 🤤 https://www.linkedin.com/posts/jeff-conroy-80a39323_i-wish-tnxp-which-i-still-own-a-paltry-01-activity-7500507145864634369-E1Pa
0 · Reply
ConsulHorkos
ConsulHorkos Aug. 31 at 7:39 PM
$NUVB just holding and waiting.
1 · Reply
AdiDasRom
AdiDasRom Aug. 31 at 5:14 PM
$NUVB Zacks rank #buy
0 · Reply
AliThePoorMan
AliThePoorMan Aug. 31 at 10:37 AM
2 · Reply
JuggernautRaider
JuggernautRaider Aug. 30 at 8:55 PM
$TNXP $NUVB $MIST $CGTX 💊 ♋️ ♥️ 🧠 Tried to warn y’all 🤫 😬 🚀
5 · Reply
Biotechs5454
Biotechs5454 Aug. 29 at 4:29 PM
$NUVB As great as Ibtrozi is, Safus is the golden child here.
0 · Reply
Bio_Invest101
Bio_Invest101 Aug. 29 at 4:02 PM
$NUVB Dr Kathy Peters from Duke https://www.neurologylive.com/view/fda-grants-fast-track-designation-safusidenib-idh1-mutant-glioma
0 · Reply
Bio_Invest101
Bio_Invest101 Aug. 28 at 4:44 PM
$IRWD $NUVB Biotech’s rebound is undeniable Know the biotech market and know what you own. Daily fluctuations will happen. https://www.biopharmadive.com/news/biotech-charts-biopharma-xbi-deals-mergers-ipos/828794/
1 · Reply
Shagg85
Shagg85 Aug. 27 at 7:05 PM
$NUVB let’s see if we can push for a nice close over 7.26
0 · Reply
Belisimo
Belisimo Aug. 27 at 11:35 AM
$NUVB Safusidenib made the top 5 https://www.onclive.com/view/the-oncfive-top-oncology-articles-for-the-week-of-8-16?utm_content=384691016&utm_medium=social&utm_source=twitter&hss_channel=tw-43051682
0 · Reply
JuggernautRaider
JuggernautRaider Aug. 27 at 10:34 AM
$NUVB sold my shares: investing elsewhere! Good luck and Godspeed 🏃‍♂️ $GSK $NVS $PFE 💊 Adios mis amigos. Vaya Con Dios! 🙏 📕
3 · Reply
CapitalMonk
CapitalMonk Aug. 26 at 11:03 PM
$NUVB Price: $6.96 (-1.97%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±1.72% RSI: 62.4 | Momentum: Strong Momentum Volume: -40.6% vs avg Volatility: 4.26% Support: $5.88 | Resistance: $7.58 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
Physical_Graffiti
Physical_Graffiti Aug. 26 at 2:08 PM
0 · Reply